Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
about
Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonismSmall molecule tools for functional interrogation of protein tyrosine phosphatasesNatural killer cell signal integration balances synapse symmetry and migrationSalicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivoSmall-molecule inhibitors of the Rce1p CaaX proteaseTyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathwayFunctional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO MutationThe LDL receptor-related protein 1 (LRP1) regulates the PDGF signaling pathway by binding the protein phosphatase SHP-2 and modulating SHP-2- mediated PDGF signaling events.The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters.Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds.Targeting PTPs with small molecule inhibitors in cancer treatmentPhosphatase inhibitors with anti-angiogenic effect in vitroSHP-2 is required for the maintenance of cardiac progenitors.Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium.Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients.Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing protein tyrosine phosphatase-2 activity in human myeloid dendritic cellsSerendipitous discovery of light-induced (In Situ) formation of an Azo-bridged dimeric sulfonated naphthol as a potent PTP1B inhibitor.Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening.Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development.Therapeutic potential of targeting the oncogenic SHP2 phosphatase.Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation.miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).CB₁ cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells.SHP-2 phosphatase activity is required for PECAM-1-dependent cell motility.Critical role of Shp2 in tumor growth involving regulation of c-MycTargeting protein tyrosine phosphatases for anticancer drug discovery.A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion.Molecular targets for the treatment of juvenile myelomonocytic leukemia.The PDL1-PD1 axis converts human TH1 cells into regulatory T cells.Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma.A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling.Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2.N-Acetyl-seryl-aspartyl-lysyl-proline inhibits ET-1-induced collagen production by preserving Src homology 2-containing protein tyrosine phosphatase-2 activity in cardiac fibroblasts.Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.
P2860
Q24303934-EF7A076F-2D42-4A5D-94B7-B6242E5CE0C4Q26852276-86A7E621-5E99-4B6B-84BC-4B893BAA8CEFQ27329782-9260FB7D-5DDD-4FC1-BDBC-0C471B6B23D5Q27659942-682787D7-1CC8-497D-AEB3-37B38887B6CEQ27700205-BDCAD292-CC76-4B1C-B8B0-0014F1782D79Q27932239-BD13F088-7FB0-4034-933F-2D86B7EFA383Q28247569-A1895EA4-AA64-410A-A0D7-54FB611689D4Q28476661-32375D9B-A6A1-490F-8DC9-AEB2C31D667FQ29147543-5853DBC1-6B7E-4E2E-98AC-D68C0D9E95DFQ31125916-2B021608-EB3E-482A-BD6D-F360A41182A1Q33353881-02ABB976-EB35-4251-8D9F-DD0DBEA6B267Q33357659-161B9C43-AC30-4591-AEF7-4F356C6AD954Q33554884-6D6F1422-DDA0-4C03-8A1D-E03B8037DB19Q33588814-7F6C31F2-D646-4063-949A-04B3B3F3F672Q33595597-8F2002AE-30AB-4D5E-8C90-5EB5B74655ECQ33728245-E77C5A40-A97B-413A-977E-A2BD45EE1054Q33739307-DDD3324E-06AA-4EBF-9066-291C2A57AE96Q33739576-E315E27E-5EBF-4CA2-9CC9-D1A910BEBE25Q33749872-686287E3-5DEA-45C6-8783-4F446FF3AD86Q33782482-DE19D1C1-0A8C-4C91-8FEE-19D8984E8D35Q33931319-057DE847-F24F-4213-BC30-5845AC664CD1Q34005613-17268F54-3F45-41E2-9811-A6C32F99C213Q34007299-4D2C2B4E-4541-43D4-B8F2-4F7DD4012323Q34061302-EEBDA97B-FABA-4D31-9E7E-29FBB63759E7Q34128696-7DA07F7D-5435-4EBA-8FF3-BACE30480263Q34130721-3466D409-9F19-49BE-8D7B-0049DC2A742AQ34194673-6A913673-F91A-40FB-A5DA-7EAB8F522B08Q34211722-238F69E1-45E0-4375-B9E8-0630C60B7C82Q34713949-82DD8293-4872-4412-AE9C-B5019E8392BCQ34789961-A95054A8-677D-4C50-8DFD-96F2495098D5Q35164251-AF4EC1F9-F964-48A8-89E5-85D41F3D1238Q35555130-2A3E8C3E-A522-4E26-A9DD-3173A08A5D4BQ35579349-E93B94DA-A8C5-4667-B841-12E44CE2533EQ35607698-5CED8D98-C6B8-4DAD-915A-BAF4D6F08D5FQ35703158-B3E14F6A-61E9-48F9-AB2A-10114B55B6D5Q35742500-075AB42D-EA5C-49D6-88CC-AC8DE6E10049Q35802247-43D9BE81-24B7-47BF-BF8A-B33A6AC415A3Q36013407-84562AD4-7800-4514-9552-57255E41CD31Q36282938-D7AEFBD1-AE86-4D7D-B6E6-0ED1B26F6F11Q36286876-C3ADD6BA-A659-4DC7-B847-711DA508AC2C
P2860
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
@ast
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
@en
type
label
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
@ast
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
@en
prefLabel
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
@ast
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
@en
P2093
P356
P1476
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
@en
P2093
Harshani R Lawrence
Liwei Chen
M L Richard Yip
Nicholas J Lawrence
Said M Sebti
Shen-Shu Sung
Wayne C Guida
P304
P356
10.1124/MOL.106.025536
P577
2006-05-22T00:00:00Z